Long-Term Remission After Cilta-cel in Patients With RRMM

<p>Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article "<a href= "https://ascopubs.org/doi/10.1200/JCO-25-00760" target="_blank" rel="noopener">Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma</a>," and the efficacy of CAR-T cell therapy in patients with heavily pretreated RRMM (relapsed/refractory multiple myeloma).</p> <p><span style= "text-decoration: underline; font-size: 12pt; font-family: arial, helvetica, sans-serif;"> <strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal" style="margin: 12.0pt 0in 12.0pt 0in;"> <span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><strong style="mso-bidi-font-weight: normal;"> <span lang="EN" xml:lang="EN">Dr. Davide Soldato:</span></strong> <span lang="EN" xml:lang="EN">Hello and welcome to <em style= "mso-bidi-font-style: normal;"><a href= "https://ascopubs.org/journal/jco/podcast">JCO Aft...